Article
Mutations in LRRK2/dardarin associated with Parkinson disease are more toxic than equivalent mutations in the homologous kinase LRRK1.
Journal of neurochemistry - 1 Jul 2007
Greggio Elisa, Lewis Patrick A, van der Brug Marcel P, Ahmad Rili, Kaganovich Alice, Ding Jinhui, Beilina Alexandra, Baker Acacia K, Cookson Mark R
Abstract excerpt
Several mutations have been found in the leucine-rich repeat kinase 2 gene (LRRK2), encoding the protein dardarin, which are associated with autosomal dominant Parkinson disease. We have previously shown that mutant LRRK2/dardarin is toxic to neurons and neuron-like cell lines in culture and that some mutations are also associated with an inclusion-body phenotype. There is a homologous kinase, LRRK1, which has a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
